Relx Plc $RELX Shares Sold by Oppenheimer Asset Management Inc.

Oppenheimer Asset Management Inc. decreased its holdings in Relx Plc (NYSE:RELX) by 5.4% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 70,431 shares of the technology company’s stock after selling 4,012 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in Relx were worth $3,827,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Larson Financial Group LLC increased its position in shares of Relx by 612.5% in the first quarter. Larson Financial Group LLC now owns 513 shares of the technology company’s stock valued at $26,000 after buying an additional 441 shares in the last quarter. WPG Advisers LLC acquired a new stake in Relx in the 1st quarter valued at $28,000. Golden State Wealth Management LLC increased its holdings in Relx by 100.0% in the 1st quarter. Golden State Wealth Management LLC now owns 588 shares of the technology company’s stock worth $30,000 after acquiring an additional 294 shares in the last quarter. Caitong International Asset Management Co. Ltd raised its position in Relx by 99.3% during the second quarter. Caitong International Asset Management Co. Ltd now owns 608 shares of the technology company’s stock worth $33,000 after acquiring an additional 303 shares during the period. Finally, Cornerstone Planning Group LLC raised its position in Relx by 325.2% during the first quarter. Cornerstone Planning Group LLC now owns 693 shares of the technology company’s stock worth $37,000 after acquiring an additional 530 shares during the period. Hedge funds and other institutional investors own 15.02% of the company’s stock.

Relx Stock Down 0.8%

RELX stock opened at $46.28 on Wednesday. Relx Plc has a 1 year low of $44.19 and a 1 year high of $56.33. The company has a debt-to-equity ratio of 2.55, a quick ratio of 0.42 and a current ratio of 0.47. The business has a 50 day simple moving average of $46.57 and a 200-day simple moving average of $50.58.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on RELX shares. Weiss Ratings reiterated a “buy (b)” rating on shares of Relx in a research report on Wednesday, October 8th. Kepler Capital Markets upgraded Relx from a “hold” rating to a “strong-buy” rating in a report on Thursday, September 18th. Wall Street Zen lowered Relx from a “buy” rating to a “hold” rating in a research note on Friday, September 5th. Morgan Stanley restated an “overweight” rating on shares of Relx in a research report on Thursday, September 11th. Finally, Barclays reiterated an “overweight” rating on shares of Relx in a research report on Tuesday, October 7th. One equities research analyst has rated the stock with a Strong Buy rating and five have given a Buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Buy”.

Relx Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.